Evidence map›Paper›PMID 37779538›Full record

ArticleThe journal of allergy and clinical immunology. Global2022

Chronic granulomatous disease presenting at age 52 with fulminant mulch pneumonitis.

Louis Marois, David Drouin, Charles Leduc, Isabel Fernandez, Hélène Manganas, Géraldine Gosse, Hugo Chapdelaine, Guilhem Cros, Emilia Liana Falcone

Abstract readCase Reports
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Reliable genetic diagnosis ofFrontiers in immunology · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Louis MaroisDepartment of Medicine, Université de Montreal, Montreal, Québec, Canada.
David DrouinDepartment of Medicine, Université de Montreal, Montreal, Québec, Canada.
Charles LeducDepartment of Pathology and Molecular Biology, Université de Montreal, Montreal, Québec, Canada.
Isabel FernandezDepartment of Microbiology, Infectiology and Immunology, Université de Montreal, Montreal, Québec, Canada.
Hélène ManganasDepartment of Medicine, Université de Montreal, Montreal, Québec, Canada.
Géraldine GosseInstitut de recherches cliniques de Montréal, Montreal, Québec, Canada.
Hugo ChapdelaineDepartment of Medicine, Université de Montreal, Montreal, Québec, Canada.
Guilhem CrosInstitut de recherches cliniques de Montréal, Montreal, Québec, Canada.
Emilia Liana FalconeDepartment of Medicine, Université de Montreal, Montreal, Québec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic granulomatous disease should be considered in adults of any age in the presence of refractory and/or atypical or fulminant pulmonary infections. This case of new large deletions in

Indexed as

Aspergillosischronic granulomatous diseaseprimary immunodeficiency

Identifiers

PMID37779538
PMCPMC10509940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.